NCT00895934 2019-05-23Vorinostat, Azacitidine, and Gemtuzumab Ozogamicin for Older Patients With Relapsed or Refractory AMLNational Cancer Institute (NCI)Phase 1/2 Completed52 enrolled 12 charts